abstract |
(57) [Summary]nThe present invention relates to a long-term synaptic transmission enhancing agent containing a compound having a brain somatostatin activating effect as an active ingredient and a method for screening a long-term synaptic transmission enhancing agent using a somatostatin releasing effect as an index. The present invention is useful for preventing and / or treating brain diseases such as dementia, amnesia, manic depression, schizophrenia, Parkinson's disease, and psychosomatic disorders. |